cromolyn sodium has been researched along with Cardiomyopathies, Primary in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berrino, L; Filippelli, A; Filippelli, W; Rossi, F; Russo, S | 1 |
Baldini, L; Candussio, L; Decorti, G; Grill, V; Klugmann, FB; Mallardi, F | 1 |
Baldini, L; Candussio, L; Decorti, G; Grill, V; Klugmann, FB; Mallardi, F; Zweyer, M | 1 |
3 other study(ies) available for cromolyn sodium and Cardiomyopathies, Primary
Article | Year |
---|---|
Cardiotoxicity of doxorubicin: effects of drugs inhibiting the release of vasoactive substances.
Topics: Animals; Aspirin; Body Weight; Calcium; Cardiomyopathies; Catecholamines; Cromolyn Sodium; Doxorubicin; Electrocardiography; Heart; Histamine; Male; Prostaglandins; Rats; Rats, Wistar; Verapamil | 1994 |
Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo.
Topics: Acetylcysteine; Animals; Cardiomyopathies; Cromolyn Sodium; Dose-Response Relationship, Drug; Doxorubicin; Histamine Release; Male; Mast Cells; p-Methoxy-N-methylphenethylamine; Rats; Rats, Inbred Strains; Theophylline | 1986 |
Amelioration of 4'-epidoxorubicin-induced cardiotoxicity by sodium cromoglycate.
Topics: Animals; Cardiomyopathies; Cromolyn Sodium; Cytoplasmic Granules; Epirubicin; Histamine Release; Male; Mast Cells; Mice; Mice, Inbred Strains; Microscopy, Electron; Rats; Rats, Inbred Strains | 1989 |